• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁纳米颗粒附着在 NK 细胞表面用于过继转移治疗中的肿瘤靶向,不会影响细胞效应功能。

Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions.

机构信息

Department of Immunology and Oncology, and NanoBiomedicine Initiative, Centro Nacional de Biotecnología (CNB)-CSIC, Madrid, Spain.

出版信息

Front Immunol. 2019 Aug 30;10:2073. doi: 10.3389/fimmu.2019.02073. eCollection 2019.

DOI:10.3389/fimmu.2019.02073
PMID:31543880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6728794/
Abstract

Adoptive cell transfer therapy is currently one of the most promising approaches for cancer treatment. This therapy has some limitations, however, such as the dispersion of -administered cells, causing only a small proportion to reach the tumor. Nanotechnological approaches could offer a solution for this drawback, as they can increase cell retention and accumulation in a region of interest. In particular, strategies employing magnetic nanoparticles (MNPs) to improve targeting of adoptively transferred T or NK cells have been explored in mice. magnetic retention is reported using the human NK cell line NK-92MI transfected with MNPs. Primary NK cells are nonetheless highly resistant to transfection, and thus we explore in here the possibility of attaching the MNPs to the NK cell surface to overcome this issue, and examine whether this association would affect NK effector functions. We assessed the attachment of MNPs coated with different polymers to the NK cell surface, and found that APS-MNP attached more efficiently to the NK-92MI cell surface. In association with MNPs, these cells preserved their main functions, exhibiting a continued capacity to degranulate, conjugate with and lyse target cells, produce IFN-γ, and respond to chemotactic signals. MNP-loaded NK-92MI cells were also retained in an capillary flow system by applying an EMF. A similar analysis was carried out in primary NK cells, isolated from mice, and expanded . These primary murine NK cells also maintained their functionality intact after MNP treatment and were successfully retained . This work therefore provides further support for using MNPs in combination with EMFs to favor specific retention of functional NK cells in a region of interest, which may prove beneficial to adoptive cell-therapy protocols.

摘要

过继细胞转移疗法是目前癌症治疗最有前途的方法之一。然而,这种疗法存在一些局限性,例如-给予的细胞分散,只有一小部分到达肿瘤。纳米技术方法可以解决这个缺点,因为它们可以增加细胞在感兴趣区域的保留和积累。特别是,使用磁性纳米粒子 (MNP) 来提高过继转移的 T 或 NK 细胞靶向性的策略已经在小鼠中进行了探索。已经报道了使用转染 MNP 的人 NK 细胞系 NK-92MI 进行磁性保留。然而,原代 NK 细胞对转染具有高度抗性,因此我们在这里探索了将 MNP 附着到 NK 细胞表面以克服这个问题的可能性,并研究这种结合是否会影响 NK 效应功能。我们评估了不同聚合物涂覆的 MNP 附着到 NK 细胞表面的情况,发现 APS-MNP 更有效地附着到 NK-92MI 细胞表面。与 MNP 结合后,这些细胞保持了其主要功能,继续具有脱颗粒、与靶细胞结合和裂解、产生 IFN-γ以及对趋化信号做出反应的能力。在施加 EMF 的情况下,负载 MNP 的 NK-92MI 细胞也可以在毛细血管流动系统中保留。对从小鼠中分离并扩增的原代 NK 细胞进行了类似的分析。这些原代小鼠 NK 细胞在 MNP 处理后仍保持其功能完整,并成功保留。因此,这项工作进一步支持将 MNP 与 EMF 结合使用,以有利于在感兴趣的区域中特异性保留功能性 NK 细胞,这可能对过继细胞治疗方案有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/49ff3f071ce4/fimmu-10-02073-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/522badf1aa01/fimmu-10-02073-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/a85e4b189385/fimmu-10-02073-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/10958436abdd/fimmu-10-02073-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/434019039329/fimmu-10-02073-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/edc1e905233e/fimmu-10-02073-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/5a294b79d8e1/fimmu-10-02073-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/49ff3f071ce4/fimmu-10-02073-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/522badf1aa01/fimmu-10-02073-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/a85e4b189385/fimmu-10-02073-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/10958436abdd/fimmu-10-02073-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/434019039329/fimmu-10-02073-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/edc1e905233e/fimmu-10-02073-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/5a294b79d8e1/fimmu-10-02073-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/6728794/49ff3f071ce4/fimmu-10-02073-g0007.jpg

相似文献

1
Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions.磁纳米颗粒附着在 NK 细胞表面用于过继转移治疗中的肿瘤靶向,不会影响细胞效应功能。
Front Immunol. 2019 Aug 30;10:2073. doi: 10.3389/fimmu.2019.02073. eCollection 2019.
2
Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8 T cells does not improve their tumour infiltration in a mouse model of cancer but promotes the retention of these cells in tumour-draining lymph nodes.磁性靶向过继转输的肿瘤特异性载药纳米颗粒 CD8 T 细胞不能改善其在癌症小鼠模型中的肿瘤浸润,反而促进这些细胞在肿瘤引流淋巴结中的滞留。
J Nanobiotechnology. 2019 Aug 6;17(1):87. doi: 10.1186/s12951-019-0520-0.
3
T cells loaded with magnetic nanoparticles are retained in peripheral lymph nodes by the application of a magnetic field.经磁场作用,负载磁性纳米颗粒的 T 细胞被滞留在外周淋巴结中。
J Nanobiotechnology. 2019 Jan 22;17(1):14. doi: 10.1186/s12951-019-0440-z.
4
Ex Vivo Expanded Human NK Cells Survive and Proliferate in Humanized Mice with Autologous Human Immune Cells.经人源化的自体人免疫细胞小鼠中,体外扩增的人自然杀伤细胞能够存活和增殖。
Sci Rep. 2017 Sep 21;7(1):12083. doi: 10.1038/s41598-017-12223-8.
5
Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells.药物上调癌胚抗原表达增强了嵌合抗原受体 NK-92MI 基因修饰自然杀伤细胞对结直肠癌细胞的细胞毒性作用。
BMC Immunol. 2018 Aug 3;19(1):27. doi: 10.1186/s12865-018-0262-z.
6
An Uncoupling of Canonical Phenotypic Markers and Functional Potency of -Expanded Natural Killer Cells.- 扩充的自然杀伤细胞的典型表型标志物与功能潜能的解偶联。
Front Immunol. 2018 Feb 2;9:150. doi: 10.3389/fimmu.2018.00150. eCollection 2018.
7
Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy.适用于过继性细胞免疫治疗的基因改造的、白细胞介素2非依赖性自然杀伤细胞系的特性分析。
Hum Gene Ther. 1999 May 20;10(8):1359-73. doi: 10.1089/10430349950018030.
8
Magnetic delivery of FeO@polydopamine nanoparticle-loaded natural killer cells suggest a promising anticancer treatment.磁性递送载有 FeO@聚多巴胺纳米颗粒的自然杀伤细胞提示一种有前景的癌症治疗方法。
Biomater Sci. 2018 Sep 25;6(10):2714-2725. doi: 10.1039/c8bm00588e.
9
Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.基因工程改造的K562细胞可显著扩增并功能性激活脐血自然杀伤细胞:过继性细胞免疫疗法的潜力。
Exp Hematol. 2017 Feb;46:38-47. doi: 10.1016/j.exphem.2016.10.003. Epub 2016 Oct 17.
10
Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against Cancer.自然杀伤细胞过继性细胞免疫治疗:利用抗癌第一道防线
Cancer J. 2015 Nov-Dec;21(6):486-91. doi: 10.1097/PPO.0000000000000156.

引用本文的文献

1
[Biomaterials of different sizes for enhanced adoptive cell transfer therapy in solid tumors].用于实体瘤增强型过继性细胞转移治疗的不同尺寸生物材料
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Jul 15;54(4):469-478. doi: 10.3724/zdxbyxb-2024-0651.
2
Loading monocytes with magnetic nanoparticles enables their magnetic control without toxicity.用磁性纳米颗粒装载单核细胞可实现对其的磁性控制且无毒。
Front Bioeng Biotechnol. 2025 Jan 8;12:1498120. doi: 10.3389/fbioe.2024.1498120. eCollection 2024.
3
Loading of CAR-T cells with magnetic nanoparticles for controlled targeting suppresses inflammatory cytokine release and switches tumor cell death mechanism.

本文引用的文献

1
Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition.铁和铁蛋白调节 MHC I 类分子的表达和 NK 细胞的识别。
Front Immunol. 2019 Feb 26;10:224. doi: 10.3389/fimmu.2019.00224. eCollection 2019.
2
Magnetic Nanoclusters Armed with Responsive PD-1 Antibody Synergistically Improved Adoptive T-Cell Therapy for Solid Tumors.磁性纳米簇武装响应性 PD-1 抗体协同增强用于实体瘤的过继性 T 细胞疗法。
ACS Nano. 2019 Feb 26;13(2):1469-1478. doi: 10.1021/acsnano.8b07141. Epub 2019 Feb 18.
3
T cells loaded with magnetic nanoparticles are retained in peripheral lymph nodes by the application of a magnetic field.
用磁性纳米颗粒加载CAR-T细胞以实现可控靶向,可抑制炎性细胞因子释放并改变肿瘤细胞死亡机制。
MedComm (2020). 2025 Jan 5;6(1):e70039. doi: 10.1002/mco2.70039. eCollection 2025 Jan.
4
Nanomaterial-based detection of circulating tumor cells and circulating cancer stem cells for cancer immunotherapy.基于纳米材料的循环肿瘤细胞和循环癌干细胞检测用于癌症免疫治疗。
Nano Converg. 2024 Dec 13;11(1):56. doi: 10.1186/s40580-024-00466-x.
5
Application of magnetic nanoparticles in adoptive cell therapy of cancer; training, guiding and imaging cells.磁性纳米颗粒在癌症过继细胞治疗中的应用;细胞的培训、引导和成像。
Nanomedicine (Lond). 2024;19(27):2315-2329. doi: 10.1080/17435889.2024.2395239. Epub 2024 Sep 11.
6
Magnetite nanoparticles: an emerging adjunctive tool for the improvement of cancer immunotherapy.磁铁矿纳米颗粒:一种用于改善癌症免疫治疗的新兴辅助工具。
Explor Target Antitumor Ther. 2024;5(2):316-331. doi: 10.37349/etat.2024.00220. Epub 2024 Apr 23.
7
Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges.嵌合抗原受体自然杀伤细胞疗法:当前进展及克服挑战的策略。
Front Immunol. 2024 Apr 25;15:1384039. doi: 10.3389/fimmu.2024.1384039. eCollection 2024.
8
Engineering mesoporous bioactive glasses for emerging stimuli-responsive drug delivery and theranostic applications.用于新兴刺激响应型药物递送和诊疗应用的工程化介孔生物活性玻璃
Bioact Mater. 2024 Jan 12;34:436-462. doi: 10.1016/j.bioactmat.2024.01.001. eCollection 2024 Apr.
9
Colorectal cancer cell membrane biomimetic ferroferric oxide nanomaterials for homologous bio-imaging and chemotherapy application.用于同源生物成像和化疗应用的结直肠癌细胞膜仿生氧化铁纳米材料。
Med Oncol. 2023 Oct 6;40(11):322. doi: 10.1007/s12032-023-02175-7.
10
Human T cells loaded with superparamagnetic iron oxide nanoparticles retain antigen-specific TCR functionality.负载超顺磁性氧化铁纳米颗粒的人 T 细胞保持抗原特异性 TCR 功能。
Front Immunol. 2023 Aug 17;14:1223695. doi: 10.3389/fimmu.2023.1223695. eCollection 2023.
经磁场作用,负载磁性纳米颗粒的 T 细胞被滞留在外周淋巴结中。
J Nanobiotechnology. 2019 Jan 22;17(1):14. doi: 10.1186/s12951-019-0440-z.
4
Current Approaches to Engineering of NK Cells for Cancer Immunotherapy.当前用于癌症免疫疗法的 NK 细胞工程方法。
Curr Pharm Des. 2018;24(24):2810-2824. doi: 10.2174/1381612824666180829113013.
5
Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.氧化铁纳米颗粒和铁基复合药物制剂的免疫效应:治疗益处、毒性、机制见解和转化考虑。
Nanomedicine. 2018 Apr;14(3):977-990. doi: 10.1016/j.nano.2018.01.014. Epub 2018 Feb 2.
6
Iron oxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in lymphocytes.氧化铁纳米颗粒诱导淋巴细胞细胞毒性、氧化应激和 DNA 损伤。
J Appl Toxicol. 2017 Oct;37(10):1232-1244. doi: 10.1002/jat.3485. Epub 2017 Jun 6.
7
External magnetic field promotes homing of magnetized stem cells following subcutaneous injection.皮下注射后,外部磁场促进磁化干细胞归巢。
BMC Cell Biol. 2017 May 26;18(1):24. doi: 10.1186/s12860-017-0140-1.
8
Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.表达嵌合型CD16-BB-ζ或CD64-BB-ζ受体的基因修饰NK-92MI细胞与治疗性抗体联合使用时表现出增强的抗癌能力。
Oncotarget. 2017 Jun 6;8(23):37128-37139. doi: 10.18632/oncotarget.16201.
9
Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy.利用荧光磁性纳米颗粒在淋巴结中对树突状细胞疫苗进行磁性富集可增强癌症免疫治疗。
Theranostics. 2016 Sep 2;6(11):2000-2014. doi: 10.7150/thno.15102. eCollection 2016.
10
The responses of immune cells to iron oxide nanoparticles.免疫细胞对氧化铁纳米颗粒的反应。
J Appl Toxicol. 2016 Apr;36(4):543-53. doi: 10.1002/jat.3282. Epub 2016 Jan 28.